HUTCHMED (China) Limited (LON:HCM - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 279.53 ($3.52) and traded as low as GBX 227 ($2.86). HUTCHMED shares last traded at GBX 232 ($2.92), with a volume of 59,463 shares changing hands.
HUTCHMED Trading Down 4.1 %
The firm has a market cap of £1.98 billion, a P/E ratio of -5,800.00 and a beta of 0.76. The company's 50 day simple moving average is GBX 273.70 and its 200-day simple moving average is GBX 279.53. The company has a quick ratio of 2.97, a current ratio of 2.81 and a debt-to-equity ratio of 11.78.
HUTCHMED Company Profile
(
Get Free Report)
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in Hong Kong and internationally. The company develops Savolitinib for the treatment of non-small cell lung cancer (NSCLC), papillary renal cell carcinoma (RCC), and gastric cancer (GC); and Fruquintinib, an inhibitor for colorectal cancer (CRC), breast cancer, gastric cancer, microsatellite stable-CRC endometrial cancer (EMC), NSCLC, RCC, gastrointestinal, cervical, and solid tumors.
Further Reading
Before you consider HUTCHMED, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HUTCHMED wasn't on the list.
While HUTCHMED currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
